Literature DB >> 28571152

Oncogenic Osteomalacia: An Approach to Diagnosis with a Case Report.

Biswajit Dey1, Debasis Gochhait2, Hema Subramanian3, Madhusudhanan Ponnusamy4.   

Abstract

Oncogenic osteomalacia, also known as tumour induced osteomalacia, is a rare paraneoplastic syndrome caused by mesenchymal tumours secreting Fibroblast Growth Factor-23 (FGF-23). The characteristic biochemical findings include hypophosphatemia and low 1,25-dihydroxy vitamin D. The differential diagnosis for hypophosphatemia are varied. We present a case of oncogenic osteomalacia in a 29-year-old female, who presented with complaints of generalized diffuse bone pain and walking difficulty for six months duration. Thus, we have discussed the approach to diagnosis in such a case.

Entities:  

Keywords:  Fibroblast growth factor-23; Phosphaturic mesenchymal tumour; Scintigraphy

Year:  2017        PMID: 28571152      PMCID: PMC5449798          DOI: 10.7860/JCDR/2017/25055.9634

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  6 in total

Review 1.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

2.  Tumor(s) induced osteomalacia--a curious case of double trouble.

Authors:  Jayaprakash Sahoo; Karthik Balachandran; Sadishkumar Kamalanathan; Ashok Kumar Das; Dilip Kumar Patro; Dhanapathi Halanaik; Bhawana Badhe
Journal:  J Clin Endocrinol Metab       Date:  2013-12-02       Impact factor: 5.958

3.  Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets.

Authors:  N Weidner; D Santa Cruz
Journal:  Cancer       Date:  1987-04-15       Impact factor: 6.860

4.  Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.

Authors:  Fadil M Hannan; Nicholas A Athanasou; James Teh; Christopher L M H Gibbons; Brian Shine; Rajesh V Thakker
Journal:  Eur J Endocrinol       Date:  2008-02       Impact factor: 6.664

5.  Oncogenic osteomalacia caused by phosphaturic mesenchymal tumours in the proximal and shaft of the tibia: a case report.

Authors:  Kongkit Pithankuakul; Tanaporn Ratanasuwan; Voranuch Thanakit; Bhasanan Sukhantanak; Piya Kiatisevi
Journal:  J Orthop Surg (Hong Kong)       Date:  2014-08       Impact factor: 1.118

6.  Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.

Authors:  Andrew L Folpe; Julie C Fanburg-Smith; Steven D Billings; Michele Bisceglia; Franco Bertoni; Justin Y Cho; Michael J Econs; Carrie Y Inwards; Suzanne M Jan de Beur; Thomas Mentzel; Elizabeth Montgomery; Michal Michal; Markku Miettinen; Stacey E Mills; John D Reith; John X O'Connell; Andrew E Rosenberg; Brian P Rubin; Donald E Sweet; Tuyethoa N Vinh; Lester E Wold; Brett M Wehrli; Kenneth E White; Richard J Zaino; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2004-01       Impact factor: 6.394

  6 in total
  3 in total

1.  Severe, reversible dysphagia and malnutrition in a patient with tumour-induced hypophosphataemia.

Authors:  Tone Ramsli; Jørgen Valeur; Mikkel Pretorius; Per Gerlyng
Journal:  BMJ Case Rep       Date:  2018-06-27

2.  Oncogenic osteomalacia and metastatic breast cancer: a case report and review of the literature.

Authors:  Constantinos Savva; Jason Adhikaree; Srinivasan Madhusudan; Kamal Chokkalingam
Journal:  J Diabetes Metab Disord       Date:  2019-03-22

3.  Phosphaturic Mesenchymal Tumor: A Case Report of a Rare Entity.

Authors:  Rawan E Hudairy; Abdelrazak Meliti; Ghadeer Mokhtar; Maram Alanazi
Journal:  Cureus       Date:  2022-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.